# US 2010/0168649 A1 · Microvascular obstruction detection and therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168649 A1
- Document ID: US20100168649A1
- Status: Published application
- Kind: A1
- Application number: 12/376,086
- Filed: 2007-08-01
- Published: 2010-07-01
- Earliest claimed: 2006-08-02
- Assignees: Osprey Medical, Inc.
- Inventors: Robert S. Schwartz; Robert A. Van Tassel
- Web page: https://patentgrep.com/patent/US20100168649A1

## CPC

- A61M 25/007: {Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked}
- A61B 5/02007: {Evaluating blood vessel condition, e.g. elasticity, compliance}
- A61B 5/0215: by means inserted into the body
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 8/00: Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B 8/06: Measuring blood flow
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 25/1011: {Multiple balloon catheters}
- A61M 37/0092: {using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis}
- A61M 2025/0002: {with a pressure sensor at the distal end}
- A61M 2025/0003: {having an additional lumen transmitting fluid pressure to the outside for measurement}
- A61M 2025/1052: {for temporarily occluding a vessel for isolating a sector}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method of detecting and treating a microvascular obstruction is provided. In one embodiment, a catheter is provided for both detecting the microvascular obstruction and treating or removing the obstruction.

## Claims

### Claim 1

A method for treating a microvascular obstruction comprising:
locating a position of said microvascular obstruction within a vasculature of a patient;
advancing a distal end of a treatment catheter through said vasculature and within proximity of said position of said microvascular obstruction;
expanding an occlusion member within said vasculature;
delivering a treatment agent between said expanding occlusion member and said microvascular obstruction; and
monitoring treatment of said microvascular obstruction.

### Claim 2 (depends on 1)

The method of claim 1, wherein said locating a position of said microvascular obstruction within a vasculature of a patient is selected from a group of: magnetic resonance imaging, ultrasound imaging, pressure measurement, vascular impedance measurement and phasic flow measurement.

### Claim 3 (depends on 1)

The method of claim 1, wherein said expanding an occlusion member within said vasculature further comprises expanding a second occlusion member within said vasculature.

### Claim 4 (depends on 1)

The method of claim 1, wherein said expanding an occlusion member within said vasculature further comprises inflating an occlusion balloon.

### Claim 5 (depends on 1)

The method of claim 1, wherein said delivering a treatment agent between said expanding occlusion member and said microvascular obstruction further comprises delivering one or more treatment agents selected from the following group: Factor X, Factor VII, a IIB/IIIA agent, Tick Anticoagulant Peptide, echistatin, Integrilin, PPACK, DPG peptide inhibitor, TNK, streptokinase, urokinase, rTPA, adenosine, nitroglycerin, sodium nitroprusside, nicorandil, Hirulog, Bivalrudin, ReoPro, eptifibatide, TAP, Heparins, LMW Heparins, Argatroban, Hirudin, Refludan/Lepirudin (Berlex), Desirudin, recombinant forms, ABCIXIMAB, Eptifibatide, Tirofiban, Alteplase, Reteplase, Tenecteplase, Factor Xz, rivaroxaban, Fodaparinux, adenosine, anti-PMN antibodies, anti-leukocyte antibodies, quinolone agents, nitrogen mustard, hydroxyurea, anti-serotonin agents, such as cinanserin, pizotifen, cyproheptadine, lysenyl, mianserin, methysergide, promethazine, octreotide, trypsin, papain, chymotrypsin, lidocaine, quinidine, amiodarone, procainamide, propofenone, and beta blockade.

### Claim 6 (depends on 1)

The method of claim 1, wherein said delivering a treatment agent between said expanding occlusion member and said microvascular obstruction further comprises disbursing said treatment agent through diffusion apertures of said catheter.

### Claim 7 (depends on 6)

The method of claim 6, wherein said disbursing said treatment agent through diffusion apertures of said catheter further comprises disbursing said treatment agent through a diffusion aperture region have a size gradient of said diffusion apertures.

### Claim 8 (depends on 1)

The method of claim 1, wherein said monitoring treatment of said microvascular obstruction further comprises measuring myocardial resistance.

### Claim 9 (depends on 8)

The method of claim 8, wherein said measuring myocardial resistance further comprises measuring flow and pressure of a fluid supplied between said expanding occlusion member and said microvascular obstruction.

### Claim 10

A method for treating an obstruction of a microvascular vessel within a patient, comprising:
advancing a distal end of a guidewire to a location in communication with said obstruction;
advancing a distal end of said treatment catheter over said guidewire to said location in communication with said obstruction;
releasing a treatment agent from said treatment catheter;
monitoring an impedance of said microvascular vessel;
stopping said releasing of said treatment agent when said impedance indicates removal of said obstruction.

### Claim 11 (depends on 10)

The method of claim 10, wherein said monitoring an impedance of said microvascular vessel comprises determining an impedance by dividing a flow measurement of said treatment agent by a pressure measurement of a location in communication with said microvascular vessel.

### Claim 12 (depends on 11)

The method of claim 11, wherein said flow measurement comprises measuring a pressure differential between a fixed resistance in communication with said microvascular vessel.

### Claim 13 (depends on 12)

The method of claim 12, wherein said pressure measurement of a location in communication with said microvascular vessel is measured with a pressure transducer coupled to said treatment catheter.

### Claim 14 (depends on 10)

The method of claim 10, further comprising exposing said obstruction to ultrasonic energy.

### Claim 15

A system for treating a microvascular obstruction comprising:
a treatment catheter comprising:
an expandable occlusion balloon disposed on a distal end of said treatment catheter;
a first lumen;
a plurality of diffusion holes in communication with said first lumen and located at said distal end of said treatment catheter; and
a selectively expandable occlusion member disposed at said distal end of said treatment catheter;
an injector in communication with said first lumen for delivering a treatment agent through said catheter; and,
an occlusion sensor for monitoring a level of blockage by said occlusion.

### Claim 16 (depends on 15)

The system of claim 15, wherein said treatment catheter further comprises a second selectively expandable occlusion member.

### Claim 17 (depends on 15)

The system of claim 15, wherein said occlusion sensor comprises a pressure port at said distal end of said treatment catheter.

### Claim 18 (depends on 15)

The system of claim 15, wherein said occlusion sensor comprises a pressure transducer at said distal end of said treatment catheter.

### Claim 19 (depends on 15)

The system of claim 15, wherein said occlusion sensor comprises a flow sensor coupled to said first lumen.

### Claim 20 (depends on 19)

The system of claim 19, wherein said flow sensor comprises a first pressure sensor and a second pressure sensor in communication with said first lumen for measuring a pressure differential of a resistance member having a fixed resistance.
